Actimmune Injection, Solution
Product Images NDC 75987-111

18 FDA label images from Horizon Therapeutics Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Actimmune (NDC 75987-111). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Horizon Therapeutics Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Actimmune 01)

Figure (Actimmune 01)
An instructional illustration showing two hands under running water from a faucet, demonstrating proper hand-washing technique.*
FDA Label Image

Figure (Actimmune 02)

Figure (Actimmune 02)
An instructional line drawing showing a hand holding a small vial of medication labeled with lot and expiration date information. The vial is intended for subcutaneous injection, consistent with typical administration instructions for injectable drugs like ACTIMMUNE (Interferon gamma-1b).*
FDA Label Image

Figure (Actimmune 03)

Figure (Actimmune 03)
An instructional diagram showing a hand holding the neck of a medicine vial, preparing to snap off the vial cap. The image is related to the preparation or handling of a drug vial, likely for injection use.*
FDA Label Image

Figure (Actimmune 04)

Figure (Actimmune 04)
An instructional illustration showing two hands preparing a syringe for injection. One hand holds the syringe with the needle pointing upwards, while the other hand is pushing the plunger as indicated by a downward arrow. This image appears to depict proper syringe preparation or air removal technique before subcutaneous injection.*
FDA Label Image

Figure (Actimmune 05)

Figure (Actimmune 05)
An illustration showing a hand holding a vial and inserting a needle from a syringe into the vial, demonstrating the process of drawing medication from the vial for injection.*
FDA Label Image

Figure (Actimmune 06)

Figure (Actimmune 06)
An instructional diagram showing a hand holding a syringe and an ampule or vial, with an arrow indicating the action of pulling or removing a cap or stopper from the syringe or vial. This likely demonstrates preparation steps for subcutaneous injection.*
FDA Label Image

Figure (Actimmune 07)

Figure (Actimmune 07)
Instructional illustration showing a hand holding a syringe with a needle pointing downward, pulling back on the plunger, likely demonstrating how to withdraw medication or remove air from the syringe prior to injection.*
FDA Label Image

Figure (Actimmune 08)

Figure (Actimmune 08)
An instructional line drawing depicting a hand holding a syringe with the thumb and index finger grasping the syringe barrel and plunger, illustrating the proper method for handling the syringe for subcutaneous injection.*
FDA Label Image

Figure (Actimmune 09)

Figure (Actimmune 09)
An instructional diagram showing the side view of a human torso with an outlined area on the upper arm indicating the subcutaneous injection site location for ACTIMMUNE injection, solution.*
FDA Label Image

Figure (Actimmune 10)

Figure (Actimmune 10)
An instructional illustration showing the lower abdominal area for subcutaneous injection, highlighting the recommended injection site in the abdomen, just above the waistline. The image suggests proper placement of the injection for ACTIMMUNE (Interferon gamma-1b) solution.*
FDA Label Image

Figure (Actimmune 11)

Figure (Actimmune 11)
An illustration showing the recommended subcutaneous injection sites on the upper outer thigh areas of both legs. The image depicts a pattern of small crosses indicating preferred injection locations.*
FDA Label Image

Figure (Actimmune 12)

Figure (Actimmune 12)
An instructional diagram showing a hand holding a syringe needle cap and twisting it, likely illustrating the step to remove the cap from a prefilled syringe or needle before injection.*
FDA Label Image

Figure (Actimmune 13)

Figure (Actimmune 13)
An instructional black-and-white line drawing showing a hand holding an injection syringe, with the other hand stabilizing the syringe barrel near the needle. The image illustrates proper handling technique for subcutaneous injection preparation or administration.*
FDA Label Image

Figure (Actimmune 14)

Figure (Actimmune 14)
An instructional line drawing showing a hand holding a syringe and needle poised for subcutaneous injection into the skin, demonstrating the injection technique typically used for ACTIMMUNE (Interferon gamma-1b) solution.*
FDA Label Image

Figure (Actimmune 15)

Figure (Actimmune 15)
An instructional illustration showing a hand injecting a solution subcutaneously with a syringe. The syringe needle is inserted beneath the skin, and an arrow indicates the direction of injection.*
FDA Label Image

Figure (Actimmune 16)

Figure (Actimmune 16)
An instructional illustration showing a hand pinching the skin, which is typically used to demonstrate the correct technique for administering a subcutaneous injection.*
FDA Label Image

Figure (Actimmune 17)

Figure (Actimmune 17)
An instructional illustration showing a hand using a syringe with a needle to draw liquid from an open vial, demonstrating the proper technique for preparing an injection solution.*
FDA Label Image

Principal Display Panel (100 mcg Vial Carton)

Principal Display Panel (100 mcg Vial Carton)
Packaging label for ACTIMMUNE (Interferon gamma-1b) injection, solution, 100 mcg strength. The carton contains 12 single-dose vials and advises to keep refrigerated. The label displays the Horizon Therapeutics logo and states the drug is Rx only. Additional text includes storage instructions, manufacturing and distribution information, and contents of each vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.